Clinical Trial Update: Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

View source ↗

Summary

A completed clinical trial from Memorial Sloan Kettering Cancer Center examining biomarkers of renal dysfunction in survivors of neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma Survivors | Status: COMPLETED